Rosuvastatin, Atorvastatin Have Comparable Efficacy for CAD
THURSDAY, Oct. 19, 2023 -- Rosuvastatin and atorvastatin have comparable efficacy for a composite outcome in adults with coronary artery disease, according to a study published online Oct. 18 in The BMJ.
Yong-Joon Lee, M.D., from the Yonsei...
Read more »